Boston, MA 10/15/2014 (wallstreetpr) – The preparedness of U.S hospitals more so health care workers is being questioned after a second nurse who had attended to the deceased Eric Thomas Duncan was diagnosed with the virus. The news has already seen biotech companies in the fight against the disease recover losses registered yesterday in the market. Lakeland Industries, Inc. (NASDAQ:LAKE) and Versar Inc. (NYSEMKT:VSR) are the biggest beneficiaries of the latest development as their stocks are already up by double-digits
Alpha Pro Tech, Ltd. (NYSEMKT:APT) and Versar both of whom are developers for protective gears are surging in the market as analysts remain concerned about the virus spreading even further. The news has cast doubts on many hospitals abilities to handle the virus while also guaranteeing the safety of the health workers tending to the patients.
The spread of the virus to two health workers has prompted authorities to keep a closer watch on a total of seventy-five health workers in Dallas. Most of whom might have come into contact with the deceased, as well as the infected nurses. Lakeland is surging BY 8.13% in the market as the demand for its Hazmat suits continues to grow.
The two nurses might have contracted the virus because of a breach of protocol in the handling of the deceased patient as all of them were wearing all the protective gear. People are already asking questions as to why Mr. Duncan was not transferred to a more capable hospital able to handle infectious diseases like Emory University in Atlanta or Nebraska Medical Center in Omaha.
Chimerix Inc. (NASDAQ:CMRX) is up in the market by 1.03% while Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR) whose experimental drug TKMR-Ebola is being used in expedited trials is surging by 2.33%. Sarepta Therapeutics Inc. (NASDAQ:SRPT) has an Ebola drug under development awaiting to see results from ongoing human trials. The company’s CEO has been quoted in the recent past stating that the company has doses that could cater for up to 100 patients. Sarepta stock also as a result of the second infection in the U.S is surging by 4.39%
Nanosphere, Inc. (NASDAQ:NSPH) is another stock that has been silent, but has since spiked, with the spread of the Ebola virus. The company recently received an FDA approval to use its Verigene EP tool in early stage diagnosis of the Ebola virus. The company’s stock is up by 6.4%
Other Stocks surging as a result of the second infection in the U.S include NewLink Genetics Corp (NASDAQ:NLNK) up by 7.56% and Protalix BioTherapeutics Inc. (NYSEMKT:PLX) up by 2.70%. Ibio Inc. (NYSEMKT:IBIO) on the other hand is down by 7.14%.
The National Nurses United has moved to defend nurses maintaining that protocols used to cater for Ebola cases were constantly changing making it difficult for some of their members to cope-up-with. The situation is, on the other hand, worsening in West Africa with more than 4,000 deaths already confirmed. The world health organization has already warned that the situation could get out of hand.